Characterization of Atherosclerosis Modifier Genes
Characterization of Atherosclerosis Modifier Genes
批准号:
7983316
负责人:
Jonathan D Smith
金额:
$46.57万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-20 至 2014-05-31
关键词:
AddressAllelesAlternative SplicingApolipoprotein EAtherosclerosisCandidate Disease GeneCellsCholesterol HomeostasisChromosomes, Human, Pair 13Chromosomes, Human, Pair 17Chromosomes, Human, Pair 19Chromosomes, Human, Pair 5CodeCongenic StrainCoronary ArteriosclerosisCoronary heart diseaseDNA ResequencingDataDiagnosticDrug Delivery SystemsEndothelial CellsEnzymesExonsFamily memberFemaleGene Expression ProfileGene Expression ProfilingGene FamilyGene-ModifiedGenesGeneticGenetic VariationGoalsHealthHumanHuman ChromosomesHuman GeneticsInflammationKnock-outKnockout MiceLeadLeukotriene B4MapsMessenger RNAMethodsMusOrthologous GenePathogenesisPathway interactionsPlayPolyunsaturated Fatty AcidsPredispositionPreventionProtein IsoformsQuantitative Trait LociRNARNA SplicingRegulationReportingResistanceRibonucleasesRisk AssessmentRoleSeveritiesTestingTranscriptTransfectionTransgenic OrganismsUnited StatesUnsaturated FatsVariantWorkYeastsapolipoprotein E-2atherogenesiscase controlcohortcongenicgene discoveryinsightlipid metabolismmacrophagemalemortalitymouse modelnovelpreventpublic health relevancesextool
中文摘要
描述(申请人提供):动脉粥样硬化性冠状动脉疾病是美国最常见的死亡原因。小鼠动脉粥样硬化模型有助于研究动脉粥样硬化的发病机制,并通过检测候选基因的低表达或过表达来鉴定动脉粥样硬化修饰基因。此外,无偏见的遗传方法已经被用来定位改变动脉粥样硬化易感性的小鼠基因的位置;现在,已经有报道成功地识别了其中的几个基因。通过品系杂交,我们分别确定了雌性和雄性小鼠中含有动脉粥样硬化易感性基因的Ath24和Ath26基因。通过使用来自菌株交叉队列的巨噬细胞的基因表达谱,我们找到了与特定转录本水平相关的遗传位点;并确定了其表达与动脉粥样硬化最相关的基因。值得注意的是,每个性别中最相关的基因都映射到了与该性别对应的Ath基因座。我们建议确认Ath24和Ath26基因的身份,并进行研究以深入了解它们的作用机制。我们还建议看看这些基因的人类同源基因中的遗传变异是否与冠状动脉疾病(CAD)有关。我们提供了初步的数据,人类在前24和26候选基因中的遗传变异实际上与冠心病有关。
公共卫生相关性:动脉粥样硬化性冠状动脉疾病(CAD)是美国最常见的死亡原因。这项拟议的研究可能会确定人类基因和途径,这些基因和途径以前没有被认为在动脉粥样硬化中发挥作用。这些可能导致诊断工具、新的药物靶点和治疗方法来预防或治疗冠心病。因此,拟议的研究解决了一个重大的健康问题,并为风险评估和预防的新模式带来了希望。
英文摘要
DESCRIPTION (provided by applicant): Atherosclerotic coronary disease is the most common cause of mortality in the United States. Mouse models of atherosclerosis have been useful for studying the pathogenesis of atherosclerosis and for the identification of atherosclerosis modifier genes by testing candidate genes through their under or over expression. Additionally, unbiased genetic methods have been used to map the loci of mouse genes that alter atherosclerosis susceptibility; and, the successful identification of a couple of these genes has now been reported. By the use of a strain intercross, we identified the Ath24 and Ath26 loci, which contain genes modifying atherosclerosis susceptibility in female and male mice, respectively. Through the use of gene expression profiling in macrophages derived from the strain intercross cohort, we found genetic loci that are associated with the levels of specific transcripts; and, we identified the genes whose expression was best correlated with atherosclerosis. Remarkably, the best correlated gene in each sex mapped to the corresponding Ath locus for that sex. We propose to confirm the identity of the Ath24 and Ath26 genes, and perform studies to gain insight into their mechanism of action. We also propose to see if genetic variation in the human orthologs of these genes is associated with coronary artery disease (CAD). We present preliminary data that human genetic variation in the top Ath24 and Ath26 gene candidates are in fact associated with CAD.
PUBLIC HEALTH RELEVANCE: Atherosclerotic coronary disease (CAD) is the most common cause of mortality in the United States. The proposed studies may identify human genes and pathways not previously recognized to play a role in atherosclerosis. These may lead to diagnostic tools, novel drug targets, and therapies to prevent or treat CAD. Thus, the proposed studies address a significant health concern and offer hope for new modes of risk assessment and prevention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 1 - Genes to Function: Causal Genes and their Roles in Cardiomyocyte and Atrial Physiology
-
批准号:10646358
-
项目类别:
-
资助金额:$50.72万
-
财政年份:2022
-
负责人:Jonathan D Smith
-
依托单位:
Project 1 - Genes to Function: Causal Genes and their Roles in Cardiomyocyte and Atrial Physiology
-
批准号:10410648
-
项目类别:
-
资助金额:$50.72万
-
财政年份:2022
-
负责人:Jonathan D Smith
-
依托单位:
Genetic modifiers of atherosclerosis and macrophage phenotypes
-
批准号:10306932
-
项目类别:
-
资助金额:$63.26万
-
财政年份:2021
-
负责人:Jonathan D Smith
-
依托单位:
Molecular Medicine Training Program at Cleveland Clinic/Case Western Reserve University
-
批准号:10426323
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2021
-
负责人:Jonathan D Smith
-
依托单位:
Molecular Medicine Training Program at Cleveland Clinic/Case Western Reserve University
-
批准号:10268038
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2021
-
负责人:Jonathan D Smith
-
依托单位:
Molecular Medicine Training Program at Cleveland Clinic/Case Western Reserve University
-
批准号:10620326
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2021
-
负责人:Jonathan D Smith
-
依托单位:
Genetic modifiers of atherosclerosis and macrophage phenotypes
-
批准号:10626053
-
项目类别:
-
资助金额:$61.88万
-
财政年份:2021
-
负责人:Jonathan D Smith
-
依托单位:
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis
-
批准号:9451333
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2016
-
负责人:Jonathan D Smith
-
依托单位:
Mechanism of ApoA1 Lipidation by ABCA1 in HDL biogenesis
-
批准号:9102483
-
项目类别:
-
资助金额:$40.76万
-
财政年份:2016
-
负责人:Jonathan D Smith
-
依托单位:
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis
-
批准号:9173990
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2016
-
负责人:Jonathan D Smith
-
依托单位:
ApoA1 lipidation by ABCA1 in HDL biogenesis
-
批准号:10206232
-
项目类别:
-
资助金额:$47.95万
-
财政年份:2016
-
负责人:Jonathan D Smith
-
依托单位:
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis
-
批准号:9276118
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2016
-
负责人:Jonathan D Smith
-
依托单位:
ApoA1 lipidation by ABCA1 in HDL biogenesis
-
批准号:10642780
-
项目类别:
-
资助金额:$47.95万
-
财政年份:2016
-
负责人:Jonathan D Smith
-
依托单位:
Atherosclerosis and Lipoprotein Analysis Core
-
批准号:8242737
-
项目类别:
-
资助金额:$26.11万
-
财政年份:2011
-
负责人:Jonathan D Smith
-
依托单位:
Characterization of Atherosclerosis Modifier Genes
-
批准号:8131145
-
项目类别:
-
资助金额:$46.65万
-
财政年份:2010
-
负责人:Jonathan D Smith
-
依托单位:
Characterization of Atherosclerosis Modifier Genes
-
批准号:8280217
-
项目类别:
-
资助金额:$46.66万
-
财政年份:2010
-
负责人:Jonathan D Smith
-
依托单位:
Characterization of Atherosclerosis Modifier Genes
-
批准号:8490709
-
项目类别:
-
资助金额:$44.42万
-
财政年份:2010
-
负责人:Jonathan D Smith
-
依托单位:
ABCA1, ApoAI and Reverse Cholesterol Transport
-
批准号:8015694
-
项目类别:
-
资助金额:$51.26万
-
财政年份:2010
-
负责人:Jonathan D Smith
-
依托单位:
Atherosclerosis and Lipoprotein Analysis Core
-
批准号:7659846
-
项目类别:
-
资助金额:$10.82万
-
财政年份:2009
-
负责人:Jonathan D Smith
-
依托单位:
Genetics of Atherosclerosis in a Murine Model
-
批准号:7786022
-
项目类别:
-
资助金额:$48.83万
-
财政年份:2009
-
负责人:Jonathan D Smith
-
依托单位:
海外基金